ABDX — Abingdon Health Income Statement
0.000.00%
Last trade - 00:00
- £18.88m
- £17.89m
- £4.05m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.28 | 5.24 | 11.6 | 2.83 | 4.04 |
Cost of Revenue | |||||
Gross Profit | 1.57 | 4.43 | 4.14 | -3.59 | 2.08 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.67 | 8.55 | 18.3 | 24.4 | 7.62 |
Operating Profit | -1.4 | -3.31 | -6.72 | -21.5 | -3.57 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.41 | -3.37 | -6.95 | -21.6 | -3.56 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.26 | -3.37 | -6.97 | -21.3 | -3.45 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.26 | -3.37 | -6.97 | -21.3 | -3.45 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.26 | -3.37 | -6.97 | -21.3 | -3.45 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.013 | -0.011 | -0.065 | -0.127 | -0.029 |
Dividends per Share |